1 completed, 1 enrolling by invitation, 1 not yet recruiting, 1 recruiting. 3 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 1, Enrolling by invitation 1, Not yet recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Metabolic Effects: new trials by email Literature Review of Metabolic Effects trials Research Report on Metabolic Effects
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Metabolic Effects of Antiretroviral Drugs in Healthy volUnteers: a Phase 2 Randomized Study Dolutegravir (DTG) AND Tenofovir alafenamide (TAF), Tenofovir Disoproxil Fumarate, Dolutegravir - Healthy Volunteer, Weight Gain | Phase 2 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 120 | 2026-09-24 | 2026-09-29 |
| Amino Acid Infusion in Kidney Transplant Recipients Infusion Therapy, Saline solution infusion - Short-term Graft Function, Metabolic Effects | Not applicable | Not yet recruiting | University Hospital, Martin | 100 | 2025-09-15 | 2025-04-16 |
| Impact of SCFA Supplementation on Gut Microbiome Composition of Kidney Transplant Recipients SCFA, Placebo - Metabolic Effects, Immunosuppressive Agents | Not applicable | Enrolling by invitation | University Hospital, Martin | 41 | 2025-04-04 | 2025-06-17 |
| Impact of SCFA Supplementation on Metabolic Profiles in Serum and Urine of Kidney Transplant Recipients. Short Chain Fatty Acid, Placebo Capsule(s) - Metabolic Effects, Immunosuppressive Agents | Not applicable | Completed | University Hospital, Martin | 41 | 2024-01-15 | 2025-06-12 |
Delayed Graft Function (1) · Diabetes Mellitus (1) · Weight Gain (1)
Pathological Conditions, Signs and Symptoms (2) · Body Weight (1) · Body Weight Changes (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Signs and Symptoms (1)
Fatty Acids, Volatile (1) · Home Infusion Therapy (1) · Tenofovir (1) · dolutegravir (1) · tenofovir alafenamide (1)
University Hospital, Martin (3) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Slovakia (3) · United States (1)